Rare diseases
Investigational molecules
Locations
Back to Bulgaria37 clinical trials in Yambol, Bulgaria across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
A Phase III Randomized Double‑Blind Study of Elecoglipron for Adults with Type 2 Diabetes on Insulin
BulgariaRandomized Phase III trial of elecoglipron plus dapagliflozin on kidney outcomes and mortality in adults with chronic kidney disease
BulgariaA Phase III Study of Elecoglipron Compared with Semaglutide for Adults with Type 2 Diabetes Mellitus
BulgariaA study to evaluate the long-term safety and effectiveness of barzolvolimab in patients with chronic spontaneous urticaria
BulgariaStudy of AZD6793 tablets to reduce flare-ups in adults with moderate to very severe chronic obstructive pulmonary disease (COPD)
BulgariaStudy of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease
BulgariaStudy on BI 690517 and Empagliflozin for Patients with Heart Failure and Preserved Ejection Fraction
BulgariaStudy on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History
BulgariaStudy on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)
BulgariaLong‑term Efficacy, Safety and Tolerability of maridebart cafraglutide in Adults with Obesity and Type 2 Diabetes
BulgariaPhase 3 Randomized Placebo‑Controlled Study of Efgartigimod Alfa in Adults with Graves’ Disease Inadequately Controlled by Antithyroid Drugs
BulgariaLong-Term Study of Imeroprubart in Adults With Graves' Disease
BulgariaThe busiest research cities in the country
What the registry says about research in the country
Clinical investigations focusing on heart failure and atrial fibrillation, evaluating new therapeutic combinations and preventive treatments.
Advanced trials exploring combination therapies with empagliflozin and innovative anticoagulation approaches.
Comprehensive research into Type 2 Diabetes and obesity management, including studies on weight reduction and glycemic control.
Investigating weekly insulin alternatives and innovative weight loss interventions.
Studies examining treatments for COPD and chronic urticaria, evaluating both established and experimental therapies.
Testing advanced inhalation therapies and targeted immunological treatments.
Investigation of treatments for chronic kidney disease with concurrent hypertension, focusing on disease progression prevention.
Evaluating innovative drug combinations to slow CKD progression.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
